Press release
Endocrine Testing Market Growth Boosted By 2026 Global Key Players Like Abbott Laboratories, Thermo Fisher Scientific, Beckman Coulter, Inc., Siemens Healthineers, bioMérieux SA, Agilent Technologies, BioRad Laboratories, AB Sciex, Quest Diagnostics
Global Endocrine Testing Market
The global endocrine testing market was valued at US$ 2.95 billion in 2017, and is expected to witness a CAGR of 4.9% over the forecast period (2018 – 2026).
Download PDF Brochure of Market Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1755
Top Key Players:
Key companies covered as a part of this study include Abbott Laboratories, Thermo Fisher Scientific, Beckman Coulter, Inc., Siemens Healthineers, bioMérieux SA, Agilent Technologies, BioRad Laboratories, AB Sciex, F-Hoffmann La Roche AG, Quest Diagnostics, and others.
Market Dynamics:
Major factor driving growth of the endocrine testing market is increasing prevalence of endocrinal disease which requires first point diagnosis. Cushing syndrome is one of major endocrinal disorder. Cushing syndrome is result of the excess exposure to hormone cortisol. Cortisol concentration may elevate due to longer treatment of chronic asthma or rheumatoid arthritis and other causes. According to American Association of Neurological Surgeon statistics, around 10-15 per million people are affected by Cushing syndrome every year. Prevalence of postmenopausal osteoporosis is high, owing to low production of estradiol in women. According to International Osteoporosis Foundation factsheet, around 30% of all postmenopausal women have osteoporosis in the US and in Europe. Among them, 40% of women suffer from one or more fragility fractures in their lifetime. Increasing ageing population is also expected to aid in growth of the endocrine testing market, owing to high prevalence of endocrinal disease. According to population Prospect report by United Nations in 2017, an estimated 962 million people are aged 60 or above in the world, which accounted for 13% of the global population. The number of older people in the world is projected to be 1.4 billion growing at annual rate of 3% by 2030.
Increasing prevalence of endocrine disorders to drive the growth of the endocrine testing market
Increasing prevalence of endocrinal disorders such as diabetes, hypo/hyperthyroidism, infertility, multiple endocrine neoplasia 1 and 2, hypo/hyperadrenocorticism and hypogonadism are expected to fuel growth of endocrine testing market. Presence of these disease can be confirmed with measurement of blood hormone level to observe imbalance in their concentration. Globally hypothyroidism and hyperthyroidism are one of fastest growing endocrinal disorder. According to American Thyroid Association, in 2017, around 20 million U.S. citizens experience thyroid annually. An estimated around 12% of the U.S. population is expected to suffer from thyroid disease in their lifetime.
Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1755
Detailed Segmentation:
• Global Endocrine Testing Market, By Product:
- Thyroid
- Insulin
- Follicle Stimulating Hormone
- Luteinizing Hormone
- Estradiol
- Testosterone
- Progesterone
- Human chorionic gonadotropin
- Prolactin
- Cortisol
- DHEA-S
- Others
• Global Endocrine Testing Market, By Diagnostic Technology:
- Immunoassay
- Tandem Mass Spectroscopy
- Monoclonal AND Polyclonal Antibody
- Sensor Technologies
- Clinical Chemistry
- Others
• Global Endocrine Testing Market, By End User:
- Hospitals
- Diagnostic Laboratories
- Others
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Endocrine Testing Market Growth Boosted By 2026 Global Key Players Like Abbott Laboratories, Thermo Fisher Scientific, Beckman Coulter, Inc., Siemens Healthineers, bioMérieux SA, Agilent Technologies, BioRad Laboratories, AB Sciex, Quest Diagnostics here
News-ID: 1379689 • Views: …
More Releases from Coherent Market Insights - Clinical Diagnostic
Western Blotting Market is Expected to Gain Popularity Across the Globe by 2026
Western blotting is a technique used for detection of protein. It is also called as immunoblotting technique wherein specific antibodies are used to detect antigens. It works on the principle of molecular weight of the proteins and specificity. Gel electrophoresis is used for the denaturation of proteins and to obtain the primary antibody. Blotting and testing is performed later where the primary antibody binds to its specific antigen. It gives…
Western Blotting Market: Future and Technological Advancement 2026 By Top Player …
Western blotting is a technique used for detection of protein. It is also called as immunoblotting technique wherein specific antibodies are used to detect antigens. It works on the principle of molecular weight of the proteins and specificity. Gel electrophoresis is used for the denaturation of proteins and to obtain the primary antibody. Blotting and testing is performed later where the primary antibody binds to its specific antigen. It gives…
Cannabis Testing Market Expansion to be Persistent During 2018 – 2026 With Top …
Cannabis testing is done for various purpose such as finding concentration of active ingredient (cannabinoids, terpene), which determines the medical potency of the cannabis. It is also tested for determining various other ingredient in given sample. For instance, to determine the pesticide residue content in the given sample that undermines the purity and efficacy. Cannabis testing also involves determination of contaminants such as fungi and bacteria (mycotoxins), which could causes…
Cannabis Testing Market Trends Estimates High Demand By 2026 With Top Key Player …
Cannabis testing products and services market is witnessing significant growth with increased government approval and loosening regulatory stringent ness over use of cannabis for commercial and recreational purpose. For instance, in February 2016, the Australian government amended the Narcotics Drugs Act 1967, to allow cultivation of cannabis for medicinal or scientific purposes under a national licensing scheme, which is expected to favor the growth of the commercial manufacturing of cannabis…
More Releases for Endocrine
Endocrine Testing: A Leading Driver Behind Impact of Diabetes Prevalence on Endo …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Endocrine Testing Industry Market Size Be by 2025?
In recent times, there has been a significant expansion in the size of the endocrine testing market. The market is projected to expand from $2.55 billion in 2024 to $2.8 billion in 2025, reflecting a compound annual growth…
Evolving Market Trends In The Endocrine Peptide Test Industry: Advancements in I …
The Endocrine Peptide Test Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Endocrine Peptide Test Market Size During the Forecast Period?
The endocrine peptide test market size has grown strongly in recent years. It will grow from $9.11 billion in 2024 to…
Key Influencer in the Endocrine Testing Market 2025: Impact of Diabetes Prevalen …
What industry-specific factors are fueling the growth of the endocrine testing market?
The growing prevalence of diabetes is also expected to drive the endocrine testing market. Similar to the peptide tests, endocrine testing is crucial for diagnosing, monitoring, and managing diabetes. As the disease becomes more prevalent, especially among younger populations, the demand for these diagnostic tests increases. According to NHS data from June 2024, diabetes diagnoses in individuals under 40…
Key Influencer in the Endocrine Peptide Test Market 2025: Impact of Diabetes Pre …
What Is the Forecasted Market Size and Growth Rate for the Endocrine Peptide Test Market?
The market size for endocrine peptide tests has significantly expanded in the recent past. The growth is slated to rise from $9.11 billion in 2024 to a significant $9.97 billion in 2025. This translates to a compound annual growth rate (CAGR) of 9.5%. The expansion during the historic phase is linked to factors like increased government…
Impact of Diabetes Prevalence on Endocrine Testing Market Growth Driver: Leading …
"What Are the Projected Growth and Market Size Trends for the Endocrine Testing Market?
In the past few years, the endocrine testing market has seen a significant expansion. The market, which is worth $2.55 billion in 2024, is projected to reach $2.8 billion in the following year, growing at a compound annual growth rate (CAGR) of 9.8%. Factors contributing to this growth during the historic period include the discovery of hormones…
Endocrine Testing Market Growth Is Attributed to Increasing Prevalence of Endocr …
Endocrine testing is an important diagnostic technique used to identify endocrine hormone level in the human body. It is utilized to diagnose hormone-related illnesses. Endocrine system consists of various glands such as pituitary gland, thyroid, pancreas, hypothalamus, and adrenal glands. Hormones secreted by these glands are used to maintain various biological functions of the body. Thus, imbalance in the concentrations of hormones may lead to certain conditions. Endocrine testing is…
